AVENUE THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
AVENUE THERAPEUTICS, INC. (ATXI) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value of $171.94 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue · last filed 2026-03-30
- AVENUE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2025-06-30 was $171.94.
- AVENUE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2025-03-31 was $0.00.
- AVENUE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2024-09-30 was $0.00.
- AVENUE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2024-03-31 was $0.00.
- AVENUE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2025 was $171.94.
- AVENUE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2022 was $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | $171.94 10-K · filed 2026-03-30 | ||
| 2025-06-30 | $171.94 10-Q · filed 2025-11-13 | ||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | ||
| 2024-03-31 | $0.00 10-Q · filed 2024-11-14 | ||
| 2022-12-31 | $0.00 10-K · filed 2025-03-31 | $13.95 10-K · filed 2024-03-18 |